Xu-Yong Lin (Qiang Han, Xu-Yong Ln, Xuyong Lin)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Diffuse Large B Cell Lymphoma

Lymph Node Metastasis

Top Venues

OncoTargets and therapy

Cellular & molecular biology letters

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xueting Gan, Yuheng Feng, Yang Liu, Xuyong Lin, Xinmiao Yu, Xuezhu Rong, Xu-Yong Lin
Identification of zinc finger MIZ-type containing 2 as an oncoprotein enhancing NAD-dependent protein deacetylase sirtuin-1 deacetylase activity to regulate Wnt and Hippo pathways in non-small-cell lung cancer. Cellular & molecular biology letters 29 (1) (2024)
Chun-Yu Li, Ya-Mei Han, Ke Xu, Shu-Yue Wu, Xu-Yong Lin, Hong-Yi Cao
Case Report: SMARCB1 (INI-1)-Deficient Carcinoma of the Nasal Cavity with Pure Yolk Sac Tumor Differentiation and Elevated Serum AFP Levels. OncoTargets and therapy 14 (2021)
Jian Zang, Ying Tian, Xuejun Jiang, Xu-Yong Lin
Appearance and morphologic features of laryngeal tuberculosis using laryngoscopy: A retrospective cross-sectional study. Medicine 99 (51) (2021)
Qiang Han, Xuezhu Rong, Xu-Yong Lin, Xiupeng Zhang, Chuifeng Fan, Huanyu Zhao, Enhua Wang
WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression. Cell death & disease 12 (4) (2021)
Man Yang, Ya-Mei Han, Qiang Han, Xue-Zhu Rong, Xiao-Fang Liu, Xu-Yong Lin
KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways. Journal of cellular and molecular medicine 25 (19) (2021)
Jinjing Zhang, Xu-Yong Lin, Yan Li, Rui Zhang
Genomic Alterations In Primary Cardiac Diffuse Large B Cell Lymphoma: A Case Report And Literature Review. OncoTargets and therapy 12 (2019)